Dosage Charts Calculator Blends & Stacks Learn Blog Peptides
Open Calculator
Blog  ›  BPC-157 vs TB-500: Simple Research Comparison Guide

BPC-157 vs TB-500: Simple Research Comparison Guide

Jun 11, 2026 4 min Healing & Recovery
TL;DR
BPC-157 is a gut-derived peptide studied mostly for soft-tissue and gut healing in animal models. TB-500 is a synthetic version of thymosin beta-4, a protein linked to cell migration and repair. Both are research-only compounds with very limited human data, so reading the science carefully matters.

Two Peptides Everyone Is Talking About

Walk through any sports-science forum and you will see them mentioned together: BPC-157 and TB-500. They are often stacked, compared, or confused. But they are quite different molecules with different stories. Let's break each one down simply.

What Is BPC-157?

BPC-157 stands for Body Protection Compound-157. It is a chain of 15 amino acids — scientists call that a pentadecapeptide — originally isolated from human stomach juice.[1] Think of it as a tiny protein fragment your gut already makes.

In preclinical (animal) research, BPC-157 has been studied for healing tendons, ligaments, and muscle tissue.[2] A 2025 systematic review covering 36 studies found it improved functional, structural, and biomechanical outcomes across multiple injury types in animal models.[3] Researchers believe it works by boosting growth hormone receptors, encouraging new blood vessel growth (called angiogenesis), and dialling down inflammatory signals.[4]

One small retrospective human study injected BPC-157 directly into painful knees. Seven of twelve patients reported relief lasting more than six months.[5] That is interesting — but it is a tiny sample, not a controlled trial.

Crucially, BPC-157 has not been approved by the FDA or equivalent agencies. Human clinical data is extremely limited, and researchers stress that large, rigorous trials are still needed.[4]

What Is TB-500?

TB-500 is a synthetic peptide based on thymosin beta-4, a naturally occurring protein found in almost every cell in the body. The "TB" literally stands for thymosin beta. Thymosin beta-4 plays a role in how cells move and organise themselves during repair — a process called cell migration.

In wound-healing research, thymosin beta-4 related peptides have been studied for promoting skin repair, reducing inflammation, and supporting blood vessel formation.[6] Like BPC-157, the bulk of this work comes from animal and cell-culture studies. Human trials are scarce.

Quick Comparison: BPC-157 vs TB-500

  • Origin: BPC-157 comes from stomach protein; TB-500 is based on a protein found body-wide in cells.
  • Main research focus: BPC-157 — gut lining, tendons, ligaments, muscle;[2] TB-500 — wound healing, skin repair, blood vessel growth.[6]
  • Mechanism: BPC-157 activates growth hormone pathways and reduces inflammation;[3] TB-500 promotes cell migration and tissue remodelling.[6]
  • Human data: Both are extremely limited — a handful of pilot studies at best.[4]
  • Regulatory status: Neither is FDA-approved for clinical use.[1]
  • Research dosing: Animal studies use a wide range; doses are not directly transferable to humans. Use our calculator to explore how published research doses are reported.

How Research Dosing Differs

In animal studies, BPC-157 is commonly administered at microgram-per-kilogram doses — often between 1 and 10 micrograms per kilogram of body weight — either injected or given orally.[2] TB-500 research in animals typically uses doses measured in milligrams, often injected subcutaneously (just under the skin) over a set number of weeks.[6]

Here is the important catch: animal doses cannot be copied directly into human use. Body size, metabolism, and biology differ enormously. Researchers use specific scaling tools to estimate equivalent doses, and even then, safety and efficacy in humans remain unproven for both peptides.[3] Our calculator helps you read and compare the numbers reported in published studies — it is a research literacy tool, not a dosing guide.

How to Choose What to Read About

Ask yourself what tissue or system interests you most as a research topic. If your focus is gut health, tendon repair, or ligament recovery, the BPC-157 literature is deeper — over 500 papers have been identified in recent reviews.[3] Check the BPC-157 chart for a structured overview.

If your interest is broader wound healing, skin repair, or the role of actin-binding proteins in recovery, the thymosin beta-4 / TB-500 literature is your starting point.[6]

Either way, approach both with healthy scepticism. Reviewers consistently note that while preclinical results are promising, the absence of robust human trials means neither peptide should be considered proven therapy.[1][4] Reading primary sources — the actual studies — is the best habit you can build.

The Bottom Line

BPC-157 and TB-500 are fascinating research molecules with distinct origins and overlapping interests in tissue repair. The science is genuinely exciting in animal models. But exciting preclinical data and proven human treatments are very different things. Stay curious, read critically, and use every tool available — including our calculator — to make sense of the numbers.

Sources

  1. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. — Pharmaceuticals (Basel, Switzerland), 2025. PMID 40005999.
  2. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. — Cell and tissue research, 2019. PMID 30915550.
  3. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. — HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 2025. PMID 40756949.
  4. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. — Current reviews in musculoskeletal medicine, 2025. PMID 40789979.
  5. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. — Alternative therapies in health and medicine, 2021. PMID 34324435.
  6. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. — Frontiers in pharmacology, 2021. PMID 34267654.
See the dosage chart — BPC-157
A 15-amino-acid peptide studied for tissue repair, tendon-to-bone healing, and gastrointes
BPC-157

FAQ

Is BPC-157 the same as TB-500?
No. BPC-157 is a 15-amino-acid peptide derived from stomach protein, studied mainly for gut and soft-tissue healing.[1] TB-500 is based on thymosin beta-4, a cell protein linked to wound healing and cell migration.[6] They have different structures, different research histories, and different proposed mechanisms, though both appear in sports and recovery research.
Are BPC-157 or TB-500 approved for human use?
No. Neither peptide has been approved by the FDA or equivalent regulatory agencies for clinical use in humans.[1] Most research has been conducted in animal models. Only a handful of small pilot studies exist in humans, and researchers consistently call for larger, well-controlled clinical trials before any conclusions about safety or efficacy can be drawn.[4]
What does research say about BPC-157 and tendon healing?
Animal studies have consistently shown BPC-157 promotes healing in tendons, ligaments, and muscles by stimulating growth hormone pathways and reducing inflammation.[2] A 2025 systematic review confirmed improved structural and biomechanical outcomes in preclinical models.[3] However, human clinical evidence remains extremely limited, and findings from animal studies cannot be directly applied to people.
How do research doses for BPC-157 and TB-500 compare?
BPC-157 animal studies typically report doses in micrograms per kilogram of body weight, while TB-500 research commonly uses milligram-level doses injected subcutaneously.[2][6] These figures are not interchangeable or transferable to humans without proper scaling. Our calculator helps you explore how doses are reported across published studies — purely as a research reading aid.
For research and educational use only. Not medical advice.